Women's Health

What Happens to DHEA-S Levels in PCOS?

Women with PCOS are significantly more likely to have elevated DHEA-S than those without — yet the relationship isn't simple. Roughly 20–30% of PCOS cases involve excess adrenal androgens rather than ovarian ones, and standard PCOS treatments often miss this distinction entirely.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
PCOSDHEA-Sadrenal androgenswomen's healthhormonal balancecortisol
What Happens to DHEA-S Levels in PCOS?

What Happens to DHEA-S Levels in PCOS?

In most women with PCOS, DHEA-S is elevated above the normal reference range — but not universally. Studies estimate that 20–30% of PCOS patients have genuinely high DHEA-S driven by the adrenal glands rather than the ovaries. The key caveat: a minority of women with PCOS have low-normal or even deficient DHEA-S, which changes the clinical picture considerably. If you're sorting through lab results, knowing which pattern you fit matters more than any generic protocol.

---

What Is DHEA-S and Why Does It Matter in PCOS?

Dehydroepiandrosterone sulfate (DHEA-S) is the sulfated, storage form of DHEA produced almost exclusively by the adrenal cortex. Unlike DHEA itself, DHEA-S has a long half-life (7–10 hours), making it a more stable and reliable marker of adrenal androgen output. It converts downstream into testosterone and estrogen, which means elevated levels can feed directly into the hyperandrogenism that defines PCOS.

PCOS is diagnosed using the Rotterdam criteria, which requires two of three features: oligo/anovulation, polycystic ovarian morphology on ultrasound, and clinical or biochemical hyperandrogenism. DHEA-S is one of the biochemical markers used to confirm hyperandrogenism when testosterone is equivocal (Azziz et al., Fertility and Sterility 2009; PMID: 19249030).

The ovaries and adrenal glands each contribute to total androgen load differently. In classic PCOS, elevated LH drives excess ovarian testosterone. In adrenal PCOS subtypes, dysregulated ACTH signaling drives excess DHEA-S. Distinguishing these two is essential because interventions targeting one pathway may have little effect on the other.

---

How Common Is Elevated DHEA-S in PCOS?

The research is consistent: a meaningful subset of women with PCOS have clinically elevated DHEA-S. A 2011 study published in the Journal of Clinical Endocrinology & Metabolism found that adrenal hyperandrogenism — characterized primarily by raised DHEA-S — was present in approximately 25% of PCOS patients studied (Alevizaki et al., JCEM 2011; PMID: 21593099). Another analysis confirmed that among women with hyperandrogenism and irregular cycles, those with elevated DHEA-S had a distinct hormonal profile compared to those with elevated testosterone alone.

Elevated DHEA-S in PCOS is associated with:

  • More pronounced acne and seborrheic skin
  • Hirsutism (particularly around the chin and upper lip)
  • Irregular cycles more resistant to lifestyle modification alone
  • Higher likelihood of insulin resistance and central adiposity
  • Worsened cardiovascular risk markers

Interestingly, DHEA-S levels in PCOS don't always track alongside testosterone — some women have high testosterone with normal DHEA-S, and vice versa. Running both markers simultaneously gives a more complete picture of androgen burden.

---

Does Stress Drive DHEA-S Elevations in PCOS?

This is one of the most common questions in PCOS communities, and for good reason. The adrenal gland produces DHEA-S in response to ACTH, the same pituitary hormone that drives cortisol release under stress. Chronic psychological and physiological stress can therefore dysregulate both cortisol and DHEA-S output simultaneously.

Several studies have measured cortisol-to-DHEA ratios in women with PCOS and found that the ratio is often skewed — with some women showing elevated cortisol alongside blunted DHEA-S (indicating adrenal exhaustion patterns) and others showing elevated DHEA-S with flatter cortisol curves. A 2014 study in Psychoneuroendocrinology measured salivary cortisol and DHEA-S in women with PCOS under a standardized stress test and found significantly altered adrenal reactivity compared to controls (Gallinelli et al., Psychoneuroendocrinology 2014; PMID: 24703166).

For women who notice flares in acne, hair shedding, or cycle irregularity during periods of high stress — this adrenal-stress connection is biologically real. Cortisol and DHEA-S are both secreted from the adrenal cortex, and anything that increases ACTH drive (poor sleep, caloric restriction, psychological stress, overtraining) can push DHEA-S upward.

Practical stress-management strategies that have measurable effects on adrenal androgen output include:

  1. Sleep optimization — Even one night of poor sleep acutely elevates morning cortisol and disrupts the DHEA-S/cortisol ratio. Prioritize 7–9 hours consistently.
  2. Resistance training (moderate volume) — Light-to-moderate strength training supports insulin sensitivity and normalizes HPA axis reactivity. High-intensity chronic overtraining can worsen it.
  3. Adaptogenic herbs — Ashwagandha (KSM-66) has clinical data showing reduced cortisol by 27–30% over 60 days in stressed adults (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Lower cortisol output can help rebalance adrenal androgen secretion.
  4. Mindfulness-based stress reduction (MBSR) — Eight-week MBSR programs have shown measurable reductions in perceived stress and salivary cortisol in women with hormonal dysregulation.
  5. Blood sugar stability — Spikes and crashes in glucose create cortisol surges. Eating protein-anchored meals with a lower glycemic load reduces one of the most underappreciated drivers of adrenal stress. If you're managing fasting glucose alongside PCOS symptoms, this connection is worth taking seriously.

---

DHEA Deficiency Symptoms: The Other Side of the Picture

While elevated DHEA-S is the more common finding in PCOS, some women — particularly those who have been on prolonged low-calorie diets, have thyroid dysfunction, or are in their late 30s and beyond — may present with low-normal or frankly deficient DHEA-S. This pattern can be masked when PCOS is the primary diagnosis.

Symptoms associated with low DHEA-S include:

  • Persistent fatigue that doesn't resolve with sleep
  • Low libido and vaginal dryness (even in younger women)
  • Depressed mood and difficulty with motivation
  • Increased susceptibility to infection
  • Accelerated skin aging and thinning hair (different pattern from androgenic alopecia)
  • Joint discomfort and reduced recovery from exercise

If you also have PCOS and hypothyroidism, it's worth reviewing the connection between TSH levels and PCOS — thyroid dysfunction can suppress adrenal output and complicate the DHEA-S picture further.

DHEA-S naturally declines with age — roughly 2–3% per year after the early 30s — but in PCOS, the starting level and trajectory matter more than any population average. A woman in her late 30s with PCOS might have a DHEA-S that has dropped from previously elevated to mid-normal, which looks reassuring on paper but represents a meaningful functional change.

---

DHEA for Sleep: Does It Help in PCOS?

One underappreciated dimension of DHEA-S dysregulation is its effect on sleep quality. DHEA is a neurosteroid — it crosses the blood-brain barrier and modulates GABA-A receptor activity, which has direct implications for sleep architecture. Studies in older adults with low DHEA have shown that supplemental DHEA improved REM sleep duration and subjective sleep quality (Friess et al., American Journal of Physiology 1995; PMID: 7771592). The mechanism involves DHEA's partial conversion to allopregnanolone, a potent GABA-positive neurosteroid.

However, for women with PCOS who already have elevated DHEA-S, supplementing additional DHEA is generally not appropriate and could worsen androgen-driven symptoms. The sleep-DHEA connection is most relevant for women with low-normal DHEA-S who are experiencing insomnia, fragmented sleep, or early-morning waking alongside their PCOS symptoms.

If sleep disruption is a prominent feature, addressing the HPA axis through non-hormonal means first — adaptogenic support, sleep hygiene, and blood sugar stability overnight — is a more targeted and safer starting point than DHEA supplementation.

---

DHEA for Anxiety: What the Evidence Actually Shows

DHEA has a modest but real evidence base for mood and anxiety. Its conversion to allopregnanolone, and its action at sigma-1 receptors in the brain, means it plays a measurable role in emotional regulation. A double-blind, placebo-controlled trial conducted at the National Institute of Mental Health found that DHEA supplementation significantly reduced depression and anxiety scores compared to placebo in individuals with low baseline DHEA-S (Schmidt et al., Archives of General Psychiatry 2005; PMID: 15753240).

For women with PCOS, anxiety is a disproportionately common comorbidity. A 2018 systematic review found that anxiety disorders occur at roughly two to three times the rate in PCOS compared to the general female population. The mechanisms are likely multifactorial: androgen dysregulation, HPA axis overactivity, and the psychological burden of a chronic condition all contribute.

Again, supplemental DHEA makes sense only when DHEA-S is confirmed low. Women with elevated DHEA-S who feel anxious are better served by addressing cortisol dysregulation, which often runs alongside. Adaptogenic support, magnesium, and B-vitamin repletion are evidence-informed first-line approaches for the anxiety-adrenal connection.

For broader non-hormonal approaches to PCOS symptom management, the strategies covered in this guide on managing PCOS without hormones are a useful complement to understanding your DHEA-S picture.

---

What This Means for Your Formula

If your DHEA-S is elevated within a PCOS context, the priority is reducing the adrenal androgen burden — not adding more androgens. If it's low, the picture shifts toward restorative support. Ones approaches this through personalized formulas built from your actual lab data, not population averages.

For women with high DHEA-S and an active stress-cortisol pattern, Ones may incorporate:

  • Ashwagandha (KSM-66, 600mg) — The most clinically substantiated adaptogen for reducing cortisol and supporting HPA axis regulation. The Chandrasekhar 2012 trial (PMID: 23439798) is the reference dose, and Ones uses the full 600mg used in that study.
  • Ones Adrenal Support blend — A proprietary system support designed to modulate adrenal function, relevant when the adrenal glands are the primary driver of androgen excess.
  • Magnesium Complex — Magnesium depletion is strongly associated with HPA hyperreactivity. Ones' Magnesium Complex uses well-absorbed forms calibrated to individual load rather than a flat dose.

For women whose DHEA-S is low-normal and whose presentation involves fatigue, mood changes, and sleep disruption, the formula shifts toward adrenal restoration and neurosteroid precursor support — with specific ingredients selected based on the full lab and symptom picture rather than a generic template.

The AI practitioner that powers Ones considers DHEA-S alongside SHBG, total testosterone, free androgen index, and cortisol markers when they're available — because DHEA-S in isolation doesn't tell the whole story.

---

Key Takeaways

  • Elevated DHEA-S occurs in roughly 20–30% of PCOS cases, driven by adrenal androgen excess rather than ovarian dysfunction — and these two subtypes often require different approaches.
  • Stress is a legitimate driver: chronic HPA axis activation via poor sleep, caloric restriction, or psychological stress can push DHEA-S upward and worsen PCOS symptoms.
  • Low DHEA-S in PCOS is less common but real, particularly in older women or those with concurrent thyroid dysfunction, and presents with fatigue, mood changes, and poor sleep rather than androgenic symptoms.
  • DHEA plays a neurosteroid role relevant to both sleep architecture and emotional regulation, but supplementation is only appropriate when levels are confirmed low — it can worsen symptoms in women with already-elevated DHEA-S.
  • Adaptogenic support, particularly KSM-66 ashwagandha at 600mg, has clinical data supporting cortisol reduction and HPA axis modulation — the most evidence-based non-hormonal lever for adrenal androgen management.
  • Always interpret DHEA-S alongside other androgens, cortisol, and thyroid markers — no single number tells the full story, and personalized lab-informed protocols consistently outperform generalized supplementation.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting or changing any supplement or treatment protocol.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading